Tuesday, 10 December 2019

Pharma News

  • Aslan gastric cancer phase II study shows +ve results

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 May, 2013

    Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule pan-HER inhibitor, in gastric cancer. Aslan001 reduced cell prolifer...Read more

  • Takeda makes massive changes in its organization

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Takeda Pharmaceutical announced the appointment of new senior leadership as well as the establishment of a new organization, realignment of current organizations, and change of o...Read more

  • Novo Nordisk to form team with diabetic athletes

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2012

    Singapore: Novo Nordisk is going to form an unique group of atheletes called Team Novo Nordisk. This will be a global sports team with more than 100 cyclists, triathletes and runners, all ...Read more

  • Sanofi, Regeneron cancer drug Zaltrap gets EU nod

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

    Singapore: European Commission has granted marketing authorization for Sanofi and Regeneron Pharmaceuticals (EC)'s Zaltrap 25mg/ml concentrate in the European Union. Zaltrap 25mg/ml solutio...Read more

  • Program for atrial fibrillation patients launched

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

    Singapore: A patient education program targeting stroke reduction for patients with atrial fibrillation is being launched in Singapore. This National Neuroscience Institute (NNI) project is...Read more

  • FDA nod for Boehringer's COPD drug Olodaterol

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jan, 2013

    Singapore: The US FDA Pulmonary-Allergy Drugs Advisory Committee (PADAC) has recommended that clinical data be included in a new drug application (NDA) providing evidence to support the ap...Read more

  • GSK sells 25 brands to Aspen Pharmacare for $270 mn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2012

    Singapore: GlaxoSmithKline (GSK) has sold 25 of its old Australian brands to South Africa-based Aspen Pharmacare for $270 million (₤172 million), including Valtrex (used for treating ...Read more

  • Torrent to acquire Eleder Pharma at $325 mn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Dec, 2013

    Singapore: India-based Torrent Pharmaceuticals plans to acquire Elder Pharmaceuticals for approximately $325 million. Elder's India Business comprises of a portfolio of over 30 brands with ...Read more

  • Low R&D output, patent cliffs drives big pharma nuts

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined with the patent cliff and a stringent US FDA approval process, is re...Read more

  • Bayer, Compugen enter $500 mn cancer deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: Israel-based Compugen and global pharmaceutical company Bayer are to jointly pursue a preclinical research program for research, development, and commercialization of antibody-ba...Read more

  • Janssen unique diabetes drug gets FDA nod

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Apr, 2013

    Singapore: Janssen Pharmaceuticals received approval for Invokana (canagliflozin) for the treatment of adults with type 2 diabetes from the US FDA. The drug is the first in a new class of m...Read more

  • Sanofi is top bidder for Elder Pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2013

    Mumbai: Sanofi has emerged, as the highest bidder for all brands of Mumbai-based Elder Pharma, valuing the Indian firm at $416 million-to-$450 million (Rs 2,500-2,700 crore). Other bidders ...Read more

  • FDA nod for Genentech pre-surgical cancer drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: Genentech, a member of the Roche Group, has recieved US FDA approval for Perjeta (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER...Read more

  • Pharma majors join hands to find new cure for TB

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

    Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, recently launched a partnership that aims to speed the discovery of esse...Read more

  • GSK to publish clinical study reports of drugs

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Feb, 2013

    Singapore: Demonstrating its commitment to clinical trial transparency, multinational pharmaceutical company GlaxoSmithKline has announced its support for the AllTrials campaign. The campa...Read more

  • GSK's Mark Reilly to return to China shortly

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2013

    Singapore: GlaxoSmithKline's former China head Mr Mark Reilly would be returning to China shortly to assist the police with the ongoing corruption probe, the British drugmaker said in a sta...Read more

  • Challenges that Japan pharma will face in 2014

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2013

    Japan, like all other developed markets, is facing the crunch of a slowing pharma industry. Furthermore, the pharma situation is about to get worse in Japan, according to Mr Fumiyoshi Sakai...Read more

  • Ex-sanofi cancer head is PharmaEngine advisor

    Pharma |  Influencers | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

    Singapore: Taiwan's PharmaEngine appointed Dr Alain Herrera as senior advisor for clinical strategy, operations, corporate strategy, licensing and alliance management. Dr Herrera previousl...Read more



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls